Radiographic and serologic response in patients with unresectable hepatocellular carcinoma receiving systemic antineoplastic treatments: A trial‐level analysis
GA Colloca, A Venturino - Cancer, 2024 - Wiley Online Library
Background In a disease like unresectable hepatocellular carcinoma, overall survival is an
inadequate outcome measure for evaluating the effectiveness of treatments given the high …
inadequate outcome measure for evaluating the effectiveness of treatments given the high …
Radiographic and serologic response in patients with unresectable hepatocellular carcinoma receiving systemic antineoplastic treatments: A trial-level analysis.
GA Colloca, A Venturino - Cancer, 2024 - europepmc.org
In a disease like unresectable hepatocellular carcinoma, overall survival is an inadequate
outcome measure for evaluating the effectiveness of treatments given the high risk of death …
outcome measure for evaluating the effectiveness of treatments given the high risk of death …
Radiographic and serologic response in patients with unresectable hepatocellular carcinoma receiving systemic antineoplastic treatments: A trial-level analysis
GA Colloca, A Venturino - Cancer, 2024 - pubmed.ncbi.nlm.nih.gov
Background In a disease like unresectable hepatocellular carcinoma, overall survival is an
inadequate outcome measure for evaluating the effectiveness of treatments given the high …
inadequate outcome measure for evaluating the effectiveness of treatments given the high …